Coaxial electrostatic spinning fibrous scaffold and preparation method thereof

A technology of coaxial electrospinning and fiber support, which is applied in fiber processing, rayon manufacturing, fiber chemical characteristics, etc., to achieve the effects of simple method, prolonged release and absorption time, and easy control.

Active Publication Date: 2014-07-02
PEKING UNIV THIRD HOSPITAL
2 Cites 4 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0006] In order to solve the problem of limitations in the application of coaxial electrospun fiber scaffo...
View more

Method used

Based on the requirements of biodegradability, mechanical properties and processability to the shell, the shell material of the embodiment of the present invention fiber support selects polycaprolactone, polylactic acid, polylactic acid-glycolic acid copolymer, poly(lactic acid -hexanol) copolymers. And because polycaprolactone has advantages such as good biocompatibility and biodegradability, good compatibility with other macromolecular polymers, good solvent solubility, preferred polycaprolactone as shell layer in the embodiment of the present invention material, thus endowing the prepared coaxial electrospun fiber scaffold 5 with excellent properties.
For spinning voltage, when applied voltage is different, in order to break the balance of surface tension and electric field force, the droplet of capillary top will produce different surface shape, influences the jet droplet and trickle that produce subsequently Size distribution, fiber morphology and the magnitude of the current it conducts. When the applied voltage is low, the initial injection point protrudes from the outside of the nozzle, and the fine jet stream will also be generated at the tip of the droplet. At this time, the diameter of the droplet is larger than the aperture of the injection needle, and the resulting nanofibers are thinner and the beads are smaller. When the voltage increases, the sprayed droplets will retract into the spraying needle, so that the spraying stream will be generated from the needle tip, and the linear density and bead density of the obtained nanofibers will also increase accordingly; the voltage continues to increase to the upper critical , then the thin stream will be directly and vigorously spra...
View more

Abstract

The invention discloses a coaxial electrostatic spinning fibrous scaffold and a preparation method thereof, belonging to the field of biological tissue engineering. The scaffold comprises an aliphatic polyester shell and a polyvinylpyrrolidone core, not only is safe and non-toxic and has excellent biocompatibility but also has the functions of loading and slowly releasing drugs and/or bioactive factors, and can be widely applied to the field of biological tissue engineering. The invention also provides the preparation method of the coaxial electrostatic spinning fibrous scaffold. The preparation method comprises the step of carrying out coaxial electrostatic spinning by using an aliphatic polyester shell solution and a polyvinylpyrrolidone core solution in the windless environment to prepare a nanoscale electrostatic spinning fibrous scaffold. The nanoscale electrostatic spinning fibrous scaffold is safe and non-toxic, has a relatively high specific surface area and porosity, and has a good slow release function as a carrier of the drugs and/or bioactive factors. The method is simple, is easy to control, and has relatively strong practicability.

Application Domain

Filament/thread formingConjugated synthetic polymer artificial filaments +2

Technology Topic

ElectrospinningChemistry +6

Image

  • Coaxial electrostatic spinning fibrous scaffold and preparation method thereof
  • Coaxial electrostatic spinning fibrous scaffold and preparation method thereof
  • Coaxial electrostatic spinning fibrous scaffold and preparation method thereof

Examples

  • Experimental program(7)

Example Embodiment

[0044] Example 1
[0045] The embodiment of the present invention provides a coaxial electrospinning fiber support 5 which includes an aliphatic polyester shell layer 51 and a polyvinylpyrrolidone core layer 52.
[0046] The embodiment of the present invention provides a coaxial electrospun fiber support 5 including an aliphatic polyester shell layer 51 and a polyvinylpyrrolidone core layer 52. Because polyvinylpyrrolidone is a safe and non-toxic water-soluble pharmaceutical intermediate and pharmaceutical adjuvant, it can be miscible or compounded with a variety of substances, making the coaxial electrospun fiber stent 5 safe, non-toxic and has excellent biocompatibility ; Because the NH or OH bond of polyvinylpyrrolidone can form an intermolecular association with a variety of drugs and/or biologically active factors, and through this association, the release time and strength of the drugs and/or biologically active factors are controlled, Extend the release and absorption time of the drug and/or biologically active factor in the body, and endow the coaxial electrospun fiber scaffold 5 with the function of loading and slow releasing the drug and/or biologically active factor. It can be seen that the safe and non-toxic coaxial electrospun fiber scaffold 5 provided by the embodiment of the present invention can be widely used in the field of biological tissue engineering.

Example Embodiment

[0047] Example 2
[0048] The present invention provides a coaxial electrospinning fiber support 5, the coaxial electrospinning fiber support 5 includes: an aliphatic polyester shell layer 51 and a polyvinylpyrrolidone core layer 52 loaded with drugs and/or biologically active factors .
[0049] By adding drugs and/or biologically active factors to the polyvinylpyrrolidone core layer 52, the prepared coaxial electrospun fiber scaffold 5 has a medicinal function and can provide targeted treatment to patients.
[0050] Specifically, the aliphatic polyester is selected from at least one of polycaprolactone, polylactic acid, polylactic acid-glycolic acid copolymer, and poly(lactic acid-hexanol) copolymer, preferably polycaprolactone.
[0051] Based on the requirements for the biodegradability, mechanical properties, and processing properties of the shell, the shell material of the fiber scaffold in the embodiment of the present invention is selected from polycaprolactone, polylactic acid, polylactic acid-glycolic acid copolymer, poly(lactic acid-hexanol) ) At least one of copolymers. Since polycaprolactone has good biocompatibility and biodegradability, good compatibility with other high molecular polymers, good solvent solubility, etc., polycaprolactone is preferred as the shell layer in the embodiments of the present invention. Material, thereby giving the prepared coaxial electrospinning fiber scaffold 5 excellent performance.
[0052] The NH or OH bond based on polyvinylpyrrolidone can form an intermolecular association with a variety of drugs and/or biologically active factors, and through the association, the release time and strength of the drugs and/or biologically active factors are controlled and prolonged The release and absorption time of the drug and/or biologically active factor in the body. It can be seen that the polyvinylpyrrolidone core layer 52 can not only serve as a carrier for drugs and/or biologically active factors, but also can effectively release the loaded drugs and/or biologically active factors, which is widely used in the field of biological tissue engineering.
[0053] Preferably, the drug is bovine serum albumin 6.
[0054] Since bovine serum albumin 6 is a widely used carrier in biochemical experiments, the drug is preferably bovine serum albumin 6 in the embodiments of the present invention. It is understandable that the drug can also be selected from other drugs such as antibiotics, vitamins, proteins and nucleic acids.
[0055] Specifically, the mass ratio of the aliphatic polyester in the aliphatic polyester shell layer, the polyvinylpyrrolidone in the polyvinylpyrrolidone core layer and the drug and/or biologically active factor is 1-1.5:0.35-0.55:0.01-0.015.
[0056] In order to better control the structure of the prepared coaxial electrospinning fiber scaffold 5, make it have a higher specific surface area and porosity, and at the same time make the drug and/or biologically active factor loading and slow release ability at a better In the embodiment of the present invention, the mass ratio of the aliphatic polyester in the aliphatic polyester shell layer, the polyvinylpyrrolidone in the polyvinylpyrrolidone core layer and the drug and/or biologically active factor is controlled within 1-1.5: 0.35-0.55. : 0.01-0.015. Preferably, the mass ratio of the aliphatic polyester in the aliphatic polyester shell layer, the polyvinylpyrrolidone in the polyvinylpyrrolidone core layer and the drug and/or biologically active factor is 1:0.5:0.013.

Example Embodiment

[0057] Example 3
[0058] As attached figure 1 As shown, the embodiment of the present invention provides a method for preparing a coaxial electrospinning fiber support, including:
[0059] Step 101: preparing an aliphatic polyester shell solution: dissolving the aliphatic polyester in an organic solvent and stirring until completely dissolved to obtain an aliphatic polyester shell solution.
[0060] Step 102: Prepare a polyvinylpyrrolidone core layer solution: dissolve the polyvinylpyrrolidone in an organic solvent, and stir until completely dissolved to obtain a polyvinylpyrrolidone core layer solution.
[0061] Step 103: In a windless environment, inject the aliphatic polyester shell solution and the polyvinylpyrrolidone core solution into the shell solution injector 1 and the core solution injector 2, respectively, and perform coaxial electrospinning to prepare a coaxial Electrospinning fiber support 5.
[0062] In the method for preparing the coaxial electrospinning fiber support 5 provided by the embodiment of the present invention, the nanometer can be prepared by coaxial electrospinning the aliphatic polyester shell solution and the polyvinylpyrrolidone core solution in a windless environment. Class electrospinning fiber scaffold, the nano electrospinning fiber scaffold is safe and non-toxic, and has a high specific surface area and porosity, so that it has a good slow-release function as a carrier of drugs and/or biologically active factors. The method of the invention is simple, easy to control and strong in practicability.

PUM

PropertyMeasurementUnit
Concentration0.14 ~ 0.16g/ml
Concentration0.0015 ~ 0.0025g/ml

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Sensor for detecting penicillin in liquid

Owner:HUAZHONG UNIV OF SCI & TECH

Self-repairing ultra-sensitive conductive electronic skin sensor material and preparation method thereof

InactiveCN109294134Agood biocompatibilityExcellent chemical cross-linking performance
Owner:FUJIAN AGRI & FORESTRY UNIV

Preparation method of water-soluble bi-colour fluorinated graphene quantum dot

ActiveCN104944403Agood biocompatibilityLow biological toxicity
Owner:LANZHOU INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Novel three-dimensional culture method of glioma stem cells and application thereof

InactiveCN103898058Agood biocompatibilityReduce wastage of patient resources and follow-up research funds
Owner:THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA

Classification and recommendation of technical efficacy words

Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products